http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-452577-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_142263c892abe19afb934954e3f0f7c2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
filingDate 1994-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2001-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d3321f85c79176845ceeaa406d14c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21c1d4f469eb38526e3a59d7464b39be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4290470c0cdd91f7f0cf8a041b7afceb
publicationDate 2001-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-452577-B
titleOfInvention Crystalline N-acetyl neuraminic acid derivatives and processes for their preparation
abstract Acetamido-2,3,4,5-tetradeoxy-4-guanidino-D-glycero-D-galacto-non-2-enopyranosonic acid in crystalline form, particularly in the form of a hydrate which exists as crystals having a low aspect ratio, or in the form of a hydrate which exists as crystals having a high aspect ratio.
priorityDate 1993-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451974567
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421210339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57471553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439197
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413958311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449913835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13541300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393644

Total number of triples: 51.